Almatica CNS

Almatica Pharma, often recognized by its focus area as Almatica CNS, is a pharmaceutical company dedicated to the development and commercialization of therapies for central nervous system disorders. Operating as a subsidiary of Alvogen, the company manages a robust portfolio of branded products primarily indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Its commercial lineup includes established brands such as Zenzedi, Evekeo, and the Quillivant XR franchise. Almatica specializes in acquiring and optimizing niche CNS brands, often utilizing advanced delivery technologies like extended-release oral suspensions and orally disintegrating tablets. The company is headquartered in Morristown, New Jersey, and serves as the branded CNS arm of its parent organization.